BIOSTAR PHARM-B (02563.HK) -0.080 (-2.010%) announced that it has resolved to exercise the 2025 mandate to repurchase H shares from time to time on the open market, up to the total number of its issued H shares. (de/d)(HK stocks quote is delayed for at least 15 mins.)
AASTOCKS Financial News